human   14624

« earlier    

A Map of the World Where the Sizes of Countries Are Determined by Population
Max Roser has constructed a cartogram of the world where the size of the countries are determined by their populations (big version of the image here). He refers to it as “the map we need if we want to think about how global living conditions are changing”.
global  world  cartography  population  human  map 
yesterday by markhgn
шрам на роже мужику всего дороже: mi3ch
На самом деле у всех мужчин есть шрам от нераскрывшегося влагалища. Мужчина и женщина получаются из одной заготовки (посмотрите на соски, которые есть у мужчин). И во время эмбрионального развития у всех людей есть «заготовка» под влагалище. С мужскими гормонами оно не раскрывается и от него остается небольшой шрам – от идет от мошонки до головки члена (снизу).
Живите теперь с этим
human  biology  physiology  funny  fact 
3 days ago by some_hren
Jeff Atwood on building Discourse, Stack Exchange, and Coding Horror - Episode #10
And another by Martin Fowler: "Any fool can write code that a computer can understand. Good programmers write code that humans can understand."

Steve Yegge came out and said that your most important skill as a programmer is marketing whether you like it or not. Why? Because no matter what you produce, people have to find it. They have to understand it and use it. These are marketing jobs.
code  Programming  marketing  human  UX 
4 days ago by akiraman
Glycemic control and vascular complications in type 2 diabetes mellitus - UpToDate
[tl;dr: Glycemic control improves microvascular outcomes in type 2 diabetes, including progression of nephropathy, manifestation and progression of retinopathy, and retinal photocoagulation; and showed a beneficial effect of intensive therapy on the development of more advanced clinical outcomes in renal disease and its precursors in the one study with long-enough follow up to assess effect. Cardiovascular risk benefit "has not been established as clearly" for type 2 as for type 1.]

Although the role of glycemic control on microvascular disease in type 2 diabetes was documented in the United Kingdom Prospective Diabetes Study (UKPDS), its role in reducing cardiovascular risk has not been established as clearly for type 2 diabetes....

improving glycemic control improves microvascular outcomes, as illustrated by the findings of a meta-analysis of randomized trials (34,912 participants) [5]. There was a reduction in the risk of microvascular complications (a composite outcome including progression of nephropathy, manifestation and progression of retinopathy, and retinal photocoagulation) in the intensive compared with standard glycemic control group (relative risk [RR] 0.88, 95% CI 0.82-0.95). There were significant reductions in risk for each of the individual components.

In other meta-analyses of trials (over 28,000 adults) evaluating the benefits of intensive versus conventional glycemic control specifically on renal outcomes, there was a statistically significant reduction in the risk of microalbuminuria and macroalbuminuria in patients randomly assigned to intensive glycemic control (risk ratios of 0.86 and 0.74, respectively) [6,7]. The reduction in risk of end-stage renal disease did not reach statistical significance (RR 0.69, 95% CI 0.46-1.05). There was no reduction in the risk of doubling of the serum creatinine level or death from renal disease (RRs 1.06 and 0.99, respectively) [6]. Of note, the majority of the trials in the meta-analyses were not of long enough duration to show a beneficial effect of glycemic control on end-stage renal disease, which typically manifests after 10 to 20 years of diabetes duration [8]. In the trials included in the meta-analyses, the absolute rates of severe renal outcomes were low in both the intensive- and conventional-therapy groups, reducing the ability of the analysis to demonstrate a benefit, if one exists. In the one trial with longer-term follow-up (United Kingdom Prospective Diabetes Study [UKPDS] cohort followed for 22 years), there was a beneficial effect of intensive therapy on the development of more advanced clinical outcomes, including renal disease
type  2  T2D  diabetes  risk  tight  management  glucose  control  blood  benefit  morbidity  mortality  microvascular  complications  kidneys  eyes  retinopathy  nephropathy  renal  disease  cardiovascular  peer-reviewed  research  review  meta-analysis  overview  in  vivo  situ  human  clinical  trial  symptoms  comorbidities  self  treatment  care 
6 days ago by Michael.Massing
How to create human-figure icons – Nucleo
How to create human-figure icons
In this tutorial, I’ll walk you through the process of designing a human-figure icon.
icons  tutorial  human  article  Inspiration  human-figure  illustration  graphicdesign 
7 days ago by gwippich

« earlier